Cariprazine Alleviates Core Behavioral Deficits in the Prenatal Valproic Acid Exposure Rat Model of Autism Spectrum Disorder

被引：1
|
作者：
Adham, Nika [1 ]
Foley, Andrew [2 ]
Hanratty, Lynsey [2 ]
Kiss, Bela [3 ]
Farkas, Bence [3 ]
Roman, Viktor [3 ]
机构：
[1] Allergan, Dublin, Ireland
[2] Berand Ltd, NovaUCD, Dublin, Ireland
[3] Gedeon Richter Plc, Budapest, Hungary
来源：
BIOLOGICAL PSYCHIATRY | 2020年 / 87卷 / 09期
关键词：
Autism; Cariprazine; Core Symptom; Social Behavior; Pharmacotherapy;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [1] Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
    Roman, Viktor
    Adham, Nika
    Foley, Andrew G.
    Hanratty, Lynsey
    Farkas, Bence
    Lendvai, Balazs
    Kiss, Bela
    PSYCHOPHARMACOLOGY, 2021, 238 (09) : 2381 - 2392
  • [2] Cariprazine Alleviates Core Behavioral Deficits in the Prenatal Valproic Acid Exposure Model of Autism Spectrum Disorder
    Adham, Nika
    Foley, Andrew
    Hanratty, Lynsey
    Kiss, Bela
    Farkas, Bence
    Roman, Viktor
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 462 - 462
  • [3] Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
    Viktor Román
    Nika Adham
    Andrew G. Foley
    Lynsey Hanratty
    Bence Farkas
    Balázs Lendvai
    Béla Kiss
    Psychopharmacology, 2021, 238 : 2381 - 2392
  • [4] Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder
    Sandhu, Arushi
    Rawat, Kajal
    Gautam, Vipasha
    Sharma, Antika
    Kumar, Anil
    Saha, Lekha
    BRAIN RESEARCH, 2023, 1815
  • [5] Galantamine reduces behavioral deficits in prenatal valproic acid-exposed mice model of autism spectrum disorder
    Yoshikawa, Misato
    Aso, Hiroaki
    Watanabe, Masahiko
    Suemaru, Katsuya
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S223 - S223
  • [6] Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder
    Luhach, Kanishk
    Kulkarni, Giriraj T.
    Singh, Vijay P.
    Sharma, Bhupesh
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2021, 73 (11) : 1460 - 1469
  • [7] Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder
    Lu, Xiao-Yu
    Li, Meng-Qing
    Li, Yong-Tao
    Yao, Jia-Yu
    Zhang, Lin-Xuan
    Zeng, Ze-Hao
    Chen, Zhao-Rong
    Li, Chang-Qi
    Zhou, Xin-Fu
    Li, Fang
    NEUROPHARMACOLOGY, 2024, 258
  • [8] Chronic Activation of the Dopaminergic Neuronal Pathway Improves Behavioral Abnormalities in the Prenatal Valproic Acid Exposure Mouse Model of Autism Spectrum Disorder
    Hara, Yuta
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (11): : 1391 - 1396
  • [9] Evidences of hypoconnectivity in the valproic acid rat model of autism spectrum disorder
    Reines, A.
    Uccelli, N.
    Traetta, M.
    Codagnone, M.
    Rosato Siri, M. V.
    Zarate, S.
    Pasquini, J. M.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 203 - 203
  • [10] Altered Developmental Trajectory in Male and Female Rats in a Prenatal Valproic Acid Exposure Model of Autism Spectrum Disorder
    Anshu, Kumari
    Nair, Ajay Kumar
    Srinath, Shoba
    Laxmi, T. Rao
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2023, 53 (11) : 4390 - 4411
12345